Cargando…

Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS

Sauromatum giganteum (Engl.) Cusimano & Hett Tuber are used in Chinese folklore medicine for treatment of neoplasms. However, the claim has not been scientifically validated. The aim of the study is to screen the antitumor bioactive fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shi-Yong, Gong, Yun-Fei, Sun, Qiu-Jia, Bai, Jing, Wang, Long, Fan, Zi-Quan, Sun, Yu, Su, Yi-Jun, Gang, Jian, Ji, Yu-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272407/
https://www.ncbi.nlm.nih.gov/pubmed/25756649
http://dx.doi.org/10.3390/molecules20034290
_version_ 1783377149418274816
author Gao, Shi-Yong
Gong, Yun-Fei
Sun, Qiu-Jia
Bai, Jing
Wang, Long
Fan, Zi-Quan
Sun, Yu
Su, Yi-Jun
Gang, Jian
Ji, Yu-Bin
author_facet Gao, Shi-Yong
Gong, Yun-Fei
Sun, Qiu-Jia
Bai, Jing
Wang, Long
Fan, Zi-Quan
Sun, Yu
Su, Yi-Jun
Gang, Jian
Ji, Yu-Bin
author_sort Gao, Shi-Yong
collection PubMed
description Sauromatum giganteum (Engl.) Cusimano & Hett Tuber are used in Chinese folklore medicine for treatment of neoplasms. However, the claim has not been scientifically validated. The aim of the study is to screen the antitumor bioactive fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber and sensitive tumor cell lines using a cytotoxicity assay in vitro and tumor transplantation method in vivo, to support its use in folk medicine. The petroleum ether fraction, chloroform fraction, ethyl acetate fraction, n-butanol fraction and water fraction were successively extracted by turn by the maceration under reflux assay. Screening of antitumor bioactive fraction and sensitive cell lines were measured by MTT assay and the serum pharmacology method, and in vivo the antitumor activities of the active fraction was evaluated by using S(180) or H(22) tumor-bearing mice model and Kunming mice. The active constituents of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett were characterized by UPLC-TOF-MS. Compared with control groups, mice serum containing ethyl acetate fraction had a inhibition effect on SMMC-7721 cell, SGC-7901 cell, MCF-7 cell, HeLa cell, A549 cell, HT-29, and MDA-MB-231, respectively, but mice serum containing other four fractions had no different with that of control group. The inhibition capabilities of mice serum containing ethyl acetate fraction on the seven cell lines in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231. In vivo the inhibition rate of 106, 318, 954 mg/kg·d ethyl acetate fraction dry extract to sarcoma S(180) is 15.22%, 26.15% and 40.24%, respectively, and life prolonging rate to hepatoma H(22) is 33.61%, 40.16% and 55.74%. A total of 14 compounds were identified in the ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett. The results of the experimental studies proved the antitumor activity of Sauromatum giganteum (Engl.) Cusimano & Hett and supported the traditional use of this plant. These data indicate the potential for the use of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber in tumor therapy, anti-tumor activity on cancer cell line in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231.
format Online
Article
Text
id pubmed-6272407
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62724072018-12-31 Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS Gao, Shi-Yong Gong, Yun-Fei Sun, Qiu-Jia Bai, Jing Wang, Long Fan, Zi-Quan Sun, Yu Su, Yi-Jun Gang, Jian Ji, Yu-Bin Molecules Article Sauromatum giganteum (Engl.) Cusimano & Hett Tuber are used in Chinese folklore medicine for treatment of neoplasms. However, the claim has not been scientifically validated. The aim of the study is to screen the antitumor bioactive fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber and sensitive tumor cell lines using a cytotoxicity assay in vitro and tumor transplantation method in vivo, to support its use in folk medicine. The petroleum ether fraction, chloroform fraction, ethyl acetate fraction, n-butanol fraction and water fraction were successively extracted by turn by the maceration under reflux assay. Screening of antitumor bioactive fraction and sensitive cell lines were measured by MTT assay and the serum pharmacology method, and in vivo the antitumor activities of the active fraction was evaluated by using S(180) or H(22) tumor-bearing mice model and Kunming mice. The active constituents of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett were characterized by UPLC-TOF-MS. Compared with control groups, mice serum containing ethyl acetate fraction had a inhibition effect on SMMC-7721 cell, SGC-7901 cell, MCF-7 cell, HeLa cell, A549 cell, HT-29, and MDA-MB-231, respectively, but mice serum containing other four fractions had no different with that of control group. The inhibition capabilities of mice serum containing ethyl acetate fraction on the seven cell lines in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231. In vivo the inhibition rate of 106, 318, 954 mg/kg·d ethyl acetate fraction dry extract to sarcoma S(180) is 15.22%, 26.15% and 40.24%, respectively, and life prolonging rate to hepatoma H(22) is 33.61%, 40.16% and 55.74%. A total of 14 compounds were identified in the ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett. The results of the experimental studies proved the antitumor activity of Sauromatum giganteum (Engl.) Cusimano & Hett and supported the traditional use of this plant. These data indicate the potential for the use of ethyl acetate fraction of Sauromatum giganteum (Engl.) Cusimano & Hett Tuber in tumor therapy, anti-tumor activity on cancer cell line in descending order is SGC-7901 > SMMC-7721 > MCF-7 > HT-29 > A549 > HeLa > MDA-MB-231. MDPI 2015-03-06 /pmc/articles/PMC6272407/ /pubmed/25756649 http://dx.doi.org/10.3390/molecules20034290 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gao, Shi-Yong
Gong, Yun-Fei
Sun, Qiu-Jia
Bai, Jing
Wang, Long
Fan, Zi-Quan
Sun, Yu
Su, Yi-Jun
Gang, Jian
Ji, Yu-Bin
Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
title Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
title_full Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
title_fullStr Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
title_full_unstemmed Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
title_short Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
title_sort screening antitumor bioactive fraction from sauromatum giganteum (engl.) cusimano & hett and sensitive cell lines with the serum pharmacology method and identification by uplc-tof-ms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272407/
https://www.ncbi.nlm.nih.gov/pubmed/25756649
http://dx.doi.org/10.3390/molecules20034290
work_keys_str_mv AT gaoshiyong screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT gongyunfei screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT sunqiujia screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT baijing screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT wanglong screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT fanziquan screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT sunyu screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT suyijun screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT gangjian screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms
AT jiyubin screeningantitumorbioactivefractionfromsauromatumgiganteumenglcusimanohettandsensitivecelllineswiththeserumpharmacologymethodandidentificationbyuplctofms